Torrent Pharma Q3 Net zooms 3-fold to Rs 483 crore
Advertisement
New Delhi: Drug firm Torrent Pharma reported around three-fold jump in consolidated net profit at Rs 483 crore for the December quarter.
The company had posted a net profit of Rs 167 crore in the same quarter of the previous fiscal, Torrent Pharmaceuticals said in a BSE filing.
Company's consolidated total income rose to Rs 1,539 crore during the quarter under review as against Rs 116.8 crore in the year-ago period, it said.
In a separate filing, the firm said its board has approved an interim dividend of Rs 20 per equity share of Rs 5.
The dividend is expected to be paid/dispatched on February 19, 2016, it added.
The company had posted a net profit of Rs 167 crore in the same quarter of the previous fiscal, Torrent Pharmaceuticals said in a BSE filing.
Company's consolidated total income rose to Rs 1,539 crore during the quarter under review as against Rs 116.8 crore in the year-ago period, it said.
In a separate filing, the firm said its board has approved an interim dividend of Rs 20 per equity share of Rs 5.
The dividend is expected to be paid/dispatched on February 19, 2016, it added.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.